Skip to main content

WPI 2285 (Propafenone Hydrochloride Extended-Release 225 mg)

Pill with imprint WPI 2285 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 225 mg. It is supplied by Actavis Pharma, Inc.

Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; atrial flutter; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2285

Propafenone Hydrochloride Extended-Release

Imprint
WPI 2285
Strength
225 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-2285
Inactive Ingredients
ferrosoferric oxide, gelatin, hypromelloses, magnesium stearate, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "WPI 2285"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.